Unlocking Intensification in Legume-Driven Systems: The Role of Markets and Input Access
Growing Africa · 05.08.2026 · 5 (1) · 2
DOI: 10.55693/ga51.dwmr4575 ↗Kurz gefasst
Fachartikel in der Zeitschrift Growing Africa, online erschienen am 05.08.2026. Verfasst von Esther Mugi-Ngenga und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Legume-based systems can drive sustainable intensification in sub-Saharan Africa (SSA), but their success, especially with legume–cereal integration and phosphorus (P) fertilization, is constrained by market access Using baseline data from 1,064 households in Ghana, Tanzania, and Malawi, this study assesses readiness to achieve productivity, nutrient use, and economic targets under Legume-Driven Intensification (LDI). Results show strong spatial variation: Tanzania relies more on intercropping but has very low fertilizer adoption (6%), while Malawi shows higher readiness (46%). Increasing distance from markets reduces commercialization and economic viability. Overall, market access critically shapes outcomes, highlighting the need for localized input delivery and spatially targeted strategies to enable effective scaling of LDI interventions.
Zitieren
APA
Mugi-Ngenga, E., Adzawla, W., Pali, P., Valencia, B., Zingore, S., & Oberthür, T. (2026). Unlocking Intensification in Legume-Driven Systems: The Role of Markets and Input Access. Growing Africa, 5(1), 2. https://doi.org/10.55693/ga51.dwmr4575
Vancouver
Mugi-Ngenga E, Adzawla W, Pali P, Valencia B, Zingore S, Oberthür T. Unlocking Intensification in Legume-Driven Systems: The Role of Markets and Input Access. Growing Africa. 2026;5(1):2. doi:10.55693/ga51.dwmr4575
BibTeX
@article{MugiNgenga2026,
author = {Mugi-Ngenga, Esther and Adzawla, William and Pali, Pamela and Valencia, Brayan and Zingore, Shamie and Oberthür, Thomas},
title = {Unlocking Intensification in Legume-Driven Systems: The Role of Markets and Input Access},
journal = {Growing Africa},
year = {2026},
volume = {5},
number = {1},
pages = {2},
doi = {10.55693/ga51.dwmr4575}
}
EUVIMED